No description available.

Streptococcus suis est un pathogène porcin et un agent de zoonose en émergence causant des maladies invasives graves. Lorsque la bactérie envahit l’hôte et se retrouve dans le sang, des neutrophiles se mobilisent rapidement pour tenter d’éliminer la menace grâce à de nombreux mécanismes anti-microbiens. Ces cellules sont régulées par le granulocyte colony-stimulating factor (G-CSF) produit lors de l’infection. Il pourrait être un acteur clé du contrôle de l’infection par S. suis mais rien n’est connu sur la production et le rôle du G-CSF dans les infections à S. suis. De plus, le recrutement et l’activation des neutrophiles demeurent peu documentés. L’hypothèse de ce projet est que S. suis induit la production du G-CSF par les cellules de l’immunité innée suite à l’infection, et que le facteur module le recrutement et l’activation des neutrophiles. Cependant, S. suis limite l’activation des cellules immunitaires et se soustrait à l’élimination par les neutrophiles grâce à ses facteurs de virulence. Le 1er objectif consistait à caractériser le recrutement et l’activation des neutrophiles en réponse à S. suis dans un modèle d’infection murin (souris C57BL/6). Nous avons démontré que S. suis cause une mobilisation rapide des neutrophiles de la moelle osseuse vers le sang et la rate. Dans le sang, les neutrophiles présentent un phénotype activé. En parallèle, l’infection cause une élévation spectaculaire du G-CSF systémique, selon un patron similaire à celui des neutrophiles, suggérant un rôle du facteur dans la mobilisation de ces cellules. Le 2e objectif visait à comprendre les mécanismes moléculaires de production de G-CSF. Nous avons donc quantifié le G-CSF produit par différentes cellules immunitaires primaires de souris et démontré que les cellules dendritiques et les macrophages produisent du G-CSF en réponse à S. suis. Les cellules reconnaissent la bactérie par l’intermédiaire de leur Toll-like receptor (TLR) 2 et de récepteurs intracellulaires, ce qui engage des voies de signalisation clés pour la production de médiateurs pro-inflammatoires. Le 3e objectif consistait à élucider le rôle du G-CSF dans le recrutement et l’activation des neutrophiles lors de l’infection par S. suis, et les conséquences sur la pathogenèse. Dans unmodèle d’infection murin, nous avons démontré que le G-CSF cause la sortie des neutrophiles de la moelle osseuse vers le sang, sans que cela augmente l’élimination de la bactérie et la réponse inflammatoire. In vitro, S. suis active peu les neutrophiles porcins, et le G-CSF ne permet pas d’augmenter leurs fonctions. Le 4e objectif avait pour but de déterminer si certains facteurs bactériens de S. suis modulent la production de G-CSF et l’activation des neutrophiles. En utilisant des mutants et des composants bactériens purifiés, nous avons démontré que pour produire le G-CSF, les cellules dendritiques et les macrophages murins reconnaissent les lipoprotéines de S. suis. Cependant, celles-ci sont partiellement masquées par la capsule qui entoure la bactérie, limitant la production de la cytokine. De la même manière, la capsule gêne l’activation optimale des neutrophiles porcins ce qui empêche leur effet bactéricide. Une meilleure compréhension de la pathogenèse des infections à S. suis pourrait orienter de nouvelles stratégies thérapeutiques en lien avec les neutrophiles pour lutter contre la bactérie. Par exemple, le G-CSF couplé à des d’autres immunomodulateurs pourra être envisagé comme traitement métaphylactique dans les élevages porcins pour prévenir d’éventuelles éclosions. / Streptococcus suis is a porcine pathogen and an emerging zoonotic agent causing severe invasive diseases. When the bacterium invades the host and enters the bloodstream, neutrophils quickly mobilize to try to eliminate the threat through various antimicrobial mechanisms. These cells are regulated by granulocyte colony-stimulating factor (G-CSF), which is produced during the infection. It could be a key player in controlling S. suis infection, but nothing is known about the production and role of G-CSF in S. suis infections. Furthermore, neutrophil recruitment and activation remain poorly documented. The hypothesis of this project is that S. suis induces G-CSF production by innate immune cells following infection, and the factor modulates the recruitment and activation of neutrophils. Nevertheless, S. suis prevents immune cells activation and evades elimination by neutrophils due to its virulence factors. The first objective was to characterize the recruitment and activation of neutrophils in response to S. suis in a murine infection model (C57BL/6). We demonstrated that S. suis infection causes a rapid release of neutrophils from the bone marrow to the blood and spleen. In the blood, neutrophils exhibit an activated phenotype. Simultaneously, the infection causes a dramatic increase in systemic G-CSF, following a pattern similar to that of neutrophils, suggesting a role for the factor in the mobilization of these cells. The second objective aimed to understand the molecular mechanisms of G-CSF production. We quantified G-CSF produced by different primary mouse immune cells and showed that dendritic cells and macrophages produce G-CSF in response to S. suis. Cells recognize the bacterium through their Toll-like receptor (TLR) 2 and intracellular receptors, engaging key signaling pathways for pro-inflammatory mediator production. The third objective was to elucidate the role of G-CSF in the recruitment and activation of neutrophils during S. suis infection, and its consequences for pathogenesis. In a murine model, we demonstrated that G-CSF causes the release of neutrophils from the bone marrow into the blood, without increasing bacterial clearance and inflammatory response. In vitro, S. suis weakly activates porcine neutrophils, and G-CSF does not enhance the cellular functions. The fourth objective aimed to determine if certain bacterial factors of S. suis modulate G-CSF production and neutrophil activation. Using mutants and purified bacterial components, we demonstrated that dendritic cells and murine macrophages recognize S. suis lipoproteins to produce G-CSF. However, these lipoproteins are partially masked by the bacterium's capsule, limiting cytokine production. Similarly, the capsule hinders optimal activation of porcine neutrophils, preventing their bactericidal effect. A better understanding of the pathogenesis of S. suis infections could guide new therapeutic strategies related to neutrophils to combat the bacterium. For example, G-CSF combined with other immunomodulators could be considered as a metaphylactic treatment in pig farming to prevent potential outbreaks.

La pneumonie est la première cause de mortalité chez l’enfant dans le monde. Elle peut être provoquée par un certain nombre d’agents pathogènes connus mais 15 à 35% des pneumonies de l’enfant restent encore non renseignées d’un point de vue étiologique. L’utilisation d’un test moléculaire de découverte de nouveaux pathogènes nous a permis de découvrir de nouvelles espèces de Torque Teno Mini Virus (TTMV, Anelloviridae), nommées TTMV-LY, dans trois épanchements pleuraux provenant d’enfants hospitalisés avec une pleuro-pneumopathie, dont l’étiologie demeurait inconnue. Les TTMV sont des virus ubiquitaires dont l’implication dans une pathologie reste à déterminer. Les voies respiratoires ayant précédemment été décrites pour être un site d'infection des anellovirus, nous avons entrepris de caractériser ces nouveaux virus, ainsi que d’étudier leur potentiel rôle dans la pathogénèse.Les génomes complets de TTMV-LY ont été isolés, caractérisés puis répliqués in vitro. La réponse des cellules épithéliales alvéolaires, ainsi que des cellules présentatrices d’antigènes (CPA), impliquées dans l’inflammation, a été étudiée après infection par les virions néo-synthétisés.Ces travaux ont démontré que : i) les TTMV-LY peuvent coloniser les poumons en profondeur, ii) les cellules pulmonaires sont permissives aux TTMV-LY et permettent une réplication virale efficace, iii) l’infection virale module les réponses cellulaires et immunitaires des cellules pulmonaires en induisant des dérégulations de l’expression génique et la production de médiateurs inflammatoires, iv) les TTMV-LY seraient capables d’interagir avec les CPA et de réguler ainsi différentiellement le processus inflammatoire.L’ensemble de ces résultats ont permis de mettre en évidence une implication potentielle des TTMV-LY dans la pathogénèse des pneumopathies, et souligné la complexité des mécanismes biologiques mis en jeu lors de l’infection par les virus de cette famille. / Pneumonia is the leading cause of death in children worldwide. It can be caused by a number of known pathogens, but 15-35% of childhood pneumonia are still not associated with an etiologic agent. A pathogen discovery assay allowed us to identify new species of Torque Teno Mini Virus (TTMV, Anelloviridae), named TTMV-LY, in three undiagnosed pleural effusions from children hospitalized with parapneumonic empyema. TTMV are ubiquitous orphan viruses, and their involvement in pathogenesis remains unknown. The respiratory tract was previously described to be a site of anellovirus detection. We investigated the role of these new species in the pathogenesis of severe pneumonia.Full-length TTMV-LY genomes were isolated and in vitro replicated. The response of alveolar epithelial cells, and antigen presenting cells (APC), both involved in the inflammation process, was studied after infection with neo-synthesized virions.This study showed for the first time that: i) TTMV-LY can deeply colonize lungs, ii) alveolar epithelial cells are permissive to the TTMV-LY and allow an efficient replication, iii) viral infection modulates cellular and innate immune responses of alveolar epithelial cells, by inducing gene expression deregulations and inflammatory mediators production, iv) TTMV-LY are able to interact with APC and thereby regulate differentially their inflammatory process.All these results allowed to highlight a potential involvement of TTMV-LY in the pathogenesis of severe pneumonia and brought out the complexity of the biological mechanisms taking place during infection by viruses of this family.

Les virus influenza aviaires faiblement pathogènes (IAFP) ciblent principalement les épithéliums des voies respiratoires et intestinales chez les poulets (Gallus gallus) infectés. Cependant, les virus influenza aviaires hautement pathogènes (IAHP) mènent à une maladie systémique fatale avec une localisation particulière aux endothéliums. L’objectif de cette thèse a été d’explorer les relations entre la réplication des virus influenza aviaires (IA) et la réponse antivirale de l’hôte dans deux modèles cellulaires originaux obtenus chez le poulet : des cellules épithéliales pulmonaires (CLEC213) et des cellules endothéliales d’aortes (chAEC). Les résultats clés sont les suivants : (i) la réplication productive des virus IA dans les chAEC dépend du clivage de l’hémagglutinine et de l’échappement viral à la réponse immunitaire innée ; (ii) les CLEC213 sont très permissives aux virus IA et présentent une faible réponse antivirale médiée par la signalisation TLR3 et MDA5 ; (iii) les fonctions régulatrices de SOCS1 et SOCS3, sur le signal des interférons et des cytokines, sont conservées chez le poulet. Nous proposons que certains virus IA peuvent exploiter les fonctions pro-virales de SOCS1 et SOCS3 à leur avantage de manière spécifique au type cellulaire. / Low pathogenic avian influenza (LPAI) viruses essentially target the epithelia of the respiratory and intestinal tract in the infected chicken host (Gallus gallus). However, highly pathogenic avian influenza (HPAI) viruses induce a peracute fatal systemic disease and exhibit a striking endothelial cell tropism. The objective of the present thesis was to explore the interdependencies of AI virus replication and the antiviral host response in two novel avian cell culture models: chicken lung epithelial cells (CLEC213) and chicken aortic endothelial cells (chAEC). The salient findings from this study are that (i) productive AI virus replication in chAEC is dependent on hemagglutinin cleavability and appears to be related to innate immune escape; (ii) CLEC213 are highly permissive to AI virus infection, due to a cell type-specific diminished TLR3- and/or MDA5-mediated antiviral signaling response; (iii) the interferon and cytokine regulatory functions of SOCS1 and SOCS3 are conserved in the chicken. Based on our data, we propose a model that predicts that certain AI viruses may exploit the proviral functions of SOCS1 and SOCS3 in a cell type-specific manner.

Universidade Federal de Uberlândia / CHAPTER II: Infection in insects stimulates a complex defensive response. Recognition of pathogens may be accomplished by plasma or hemocyte proteins that bind specifically to bacterial or fungal polysaccharides. Several morphologically distinct hemocyte cell types cooperate in the immune response. Hemocytes attach to invading organisms and then isolate them by phagocytosis, by trapping them in hemocyte aggregates called nodules, or by forming an organized multicellular capsule around large parasites. In the current investigation the cellular population in the hemolymph third instar larvae of M. scutellaris has been characterized by means of light microscopy analysis and phagocytosis assays were performed in vivo by injection of 0,5μm fluorescence beads in order to identify the hemocyte types involved in phagocytosis. Four morphotypes of circulating hemocytes were found in 3rd instar larvae: prohemocytes, plasmatocytes, granulocytes and oenocytoids. The results presented plasmatocytes and granulocytes involved in phagocytic response of foreign particles in 3rd instar larvae of M. scutellaris. CHAPTER III: Insects are continuously exposed to potentially pathogenic microorganisms and eukaryotic parasites, but only a few encounters result in infection. Insects possess a complex and efficient system of biological defense against pathogens and parasites. This system involves the following: the integument and gut as physical barriers to infection, coordinated responses of several subpopulations of hemocytes when these barriers are breached, and the induced synthesis of antimicrobial peptides and proteins, primarily by the fat body. The purpose in the present study was to verify a Toll receptor (MsToll) expression in Melipona scutellaris. By semiquantitative RT-PCR we evaluate the MsToll levels at different development stages and in different M. scutellaris workers tissues. The MsToll expression in the immune response was evaluated by real time RT-PCR in workers infected with Escherichia coli (gram-negative). Our data showed lower MsToll expression in the larval stage compared with other development stages. The specific tissue analysis showed that its expression in intestine was significantly higher compared with other tissues analyzed. Furthermore, the MsToll levels in innate immune response of M. scutellaris showed four folds enhanced in bees infected with E. coli compared with control. / CAPITULO II: Infecção em insetos estimula uma resposta defensiva complexa. O reconhecimento de patógenos pode ser realizado pelos hemócitos ou proteínas que se ligam especificamente em microorganismos com padrões moleculares específicos, os chamados (PAMPs). Diferentes células da hemolinfa cooperam na resposta imune. Os hemócitos reconhecem os patógenos e os isolam por fagocitose, formando nódulos ou, cápsula multicelular em torno do parasita. Nesse trabalho foram identificadas as células da hemolinfa da abelha sem ferrão Melipona scutellaris e caracterizados os hemócitos envolvidos no processo de fagocitose utilizando beads de 0,5μm de diâmetro, em média, com fluorescência vermelha. Na hemolinfa do 3° instar larval de M. scutellaris foram distinguidos quatro tipos de hemócitos: prohemócitos, plasmatócitos, granulócitos e oenocitóides. No ensaio de fagocitose foram identificados plasmatócitos e granulócitos, com beads fluorescentes fagocitados no citoplasma. CAPITULO III: Insetos são continuamente expostos a microrganismos potencialmente patogênicos, mas apenas alguns contatos resultam em infecção. Insetos possuem um complexo e eficiente sistema de defesa contra patógenos e parasitas, que envolve o tegumento e intestino como barreiras físicas para infecção; respostas coordenadas de vários tipos de hemócitos quando estas barreiras são violadas e a síntese de peptídeos antimicrobianos e proteínas, principalmente pelo corpo gorduroso. Nosso objetivo foi clonar e sequenciar parcialmente um gene do sistema imune inato MsToll da abelha Melipona scutellaris. Por análises de RT-PCR semiquantitativo avaliou-se os níveis de expressão de MsToll em diferentes estágios do desenvolvimento e em diferentes tecidos de operárias de M. scutellaris. A expressão de MsToll na resposta imune foi avaliada por RT-PCR tempo real em operarias infectadas com Escherichia coli (gram-negativa). Os resultados mostraram menor expressão do gene MsToll nos estágios larvais quando comparados com os demais estágios do desenvolvimento. A análise tecido específico de MsToll mostrou que em intestino sua expressão foi significativamente maior quando relacionado com os demais tecidos analisados. Com relação aos níveis de MsToll na resposta imune observou-se o aumentou de quatro vezes dos níveis desse transcrito em abelhas infectadas com E. coli comparadas com o controle. / Mestre em Genética e Bioquímica

No description available.

<p>The innate host response to virus infection is largely dominated by the production of type I interferons (IFNs). Fibroblasts, considered nonprofessional immune cells, respond to virus infection after recognition of viral components such as double-stranded (ds)RNA. The constitutively expressed transcription factor IFN regulatory factor 3 (IRF3) is rapidly activated and type I IFNs are produced. In the absence of IRF3, it was found that IFNs are still produced. This thesis identifies IRF9 as the transcription factor responsible for IFN production in the absence of IRF3 based on its ability to bind the murine (m)IFNβ promoter determined via oligonucleotide pull-down assays.</p> <p>In the absence of both IRF3 and IRF9, primary fibroblasts are deficient for IFN signalling. Surprisingly, significant inhibition of virus replication following dsRNA treatment of cells deficient for IRF3 and IFN signalling was recently observed with the large DNA virus herpes simplex virus type 1 (HSV-1) being more susceptible to inhibition than the small RNA virus vesicular stomatitis virus (VSV). As nitric oxide is known for its nonspecific antiviral effects against DNA viruses, involvement of this molecule in the antiviral response to HSV-1 in the absence of IRF3 and type I IFN induction and signalling was investigated. Here it is shown that in the absence of IRF3 and IFN, nitric oxide constitutes a major component of the innate response against HSV-1 in response to dsRNA in primary fibroblasts. In these cells, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and IRF1 regulate inducible nitric oxide synthase (iNOS) expression, subsequently producing nitric oxide. As most viruses encode strategies to render their environment IRF3 and/or IFN deficient, it appears that IRF9 and nitric oxide serve as secondary responses to protect the host against viral infection. These data emphasize the importance and requirement of the host to employ multiple strategies to overcome infection.</p> / Master of Science (MSc)

Les cellules endothéliales (EC) constituent une première barrière physique à la dissémination de virus pléiotropiques circulant par voie hématogène mais leur contribution à la défense innée anti-virale est peu connue. Des dysfonctions des EC de la barrière hémato-encéphalique (BMEC) et des sinusoïdes hépatiques (LSEC) ont été rapportées dans des neuropathologies et des hépatites aiguës ou chroniques d’origine virale, suggérant que des atteintes à leur intégrité contribuent à la pathogenèse. Les sérotypes de coronavirus de l’hépatite murine (MHV), se différenciant par leur capacité à induire des hépatites et des maladies neurologiques de sévérité variable et/ou leur tropisme pour les EC, représentent des modèles viraux privilégiés pour déterminer les conséquences de l’infection des EC sur la pathogenèse virale. Lors d’infection par voie hématogène, le sérotype MHV3, le plus virulent des MHV, induit une hépatite fulminante, caractérisée par une réponse inflammatoire sévère, et des lésions neurologiques secondaires alors que le sérotype moins virulent, MHV-A59, induit une hépatite modérée sans atteintes secondaires du système nerveux central (SNC). Par ailleurs, le sérotype MHV3, à la différence du MHV-A59, démontre une capacité à stimuler la production de cytokines par la voie TLR2. Les variants atténués du MHV3, les virus 51.6-MHV3 et YAC-MHV3, sont caractérisés par un faible tropisme pour les LSEC et induisent respectivement une hépatite modérée et subclinique. Compte tenu de l’importance des LSEC dans le maintien de la tolérance hépatique et de l’élimination des pathogènes circulants, il a été postulé que la sévérité de l’hépatite et de la réponse inflammatoire lors d’infections par les MHV est associée à la réplication virale et à l’altération des propriétés tolérogéniques et vasculaires des LSEC. Les désordres inflammatoires hépatiques pourraient résulter d’une activation différentielle du TLR2, plutôt que des autres TLR et des hélicases, selon les sérotypes. D’autre part, compte tenu du rôle des BMEC dans la prévention des infections du SNC, il a été postulé que l’invasion cérébrale secondaire par les coronavirus est reliée à l’infection des BMEC et le bris subséquent de la barrière hémato-encéphalique (BHE). À l’aide d’infections in vivo et in vitro par les différents sérotypes MHV, chez des souris ou des cultures de BMEC et de LSEC, nous avons démontré, d’une part, que l’infection in vitro des LSEC par le sétotype MHV3, à la différence des variants 51.6- et YAC-MHV3, altérait la production du facteur vasodilatant NO et renversait leur phénotype tolérogénique en favorisant la production de cytokines et de chimiokines inflammatoires. Ces dysfonctions se traduisaient in vivo par une réponse inflammatoire incontrôlée et une dérégulation du recrutement intrahépatique de leucocytes, favorisant la réplication virale et les dommages hépatiques. Nous avons aussi démontré, à l’aide de souris TLR2 KO et de LSEC dont l’expression du TLR2 a été abrogée par des siRNA, que la sévérité de l’hépatite et de la réponse inflammatoire induite par le sérotype MHV3, dépendait en partie de l’induction et de l’activation préférentielle du TLR2 par le virus dans le foie. D’autre part, la sévérité de la réplication virale au foie et des désordres dans le recrutement leucocytaire intrahépatique induits par le MHV3, et non par le MHV-A59 et le 51.6-MHV3, corrélaient avec une invasion virale subséquente du SNC, au niveau de la BHE. Nous avons démontré que l’invasion cérébrale du MHV3 était associée à une infection productive des BMEC et l’altération subséquente des protéines de jonctions serrées occludine, VE-cadhérine et ZO-1 se traduisant par une augmentation de la perméabilité de la BHE et l’entrée consécutive du virus dans le cerveau. Dans l’ensemble, les résultats de cette étude mettent en lumière l’importance du maintien de l’intégrité structurale et fonctionnelle des LSEC et des BMEC lors d’infections virales aigües par des MHV afin de limiter les dommages hépatiques associés à l’induction d’une réponse inflammatoire exagérée et de prévenir le passage des virus au cerveau suite à une dissémination par voie hématogène. Ils révèlent en outre un nouveau rôle aggravant pour le TLR2 dans l’évolution de l’hépatite virale aigüe ouvrant la voie à de nouvelles avenues thérapeutiques visant à moduler l’activité inflammatoire du TLR2. / Endothelial cells (EC) act as a physical barrier against invasion by pleiotropic blood borne viruses but their contribution in innate antiviral defense is poorly known. Dysfunctions in blood-brain barrier EC (BMECs) and liver sinusoidal EC (LSECs) have been reported in viral neuropathologies and hepatitis, suggesting that loss of ECs integrity may contribute to the pathogenesis. Mouse hepatitis coronaviruses (MHV), differing in their ability to induce severe to subclinical hepatitis and neurological diseases and / or their tropism for ECs, are relevant viral models to study the consequences of EC infection in viral pathogenesis. Following hematogenous infection, the MHV3 serotype, the most virulent MHV, induces fulminant hepatitis, characterized by severe inflammatory response, followed by neurological damage whereas the less virulent MHV-A59 serotype induces milder hepatitis but does not invade the central nervous system (CNS). In addition, MHV3, in contrast to MHV-A59, shows ability to induce TLR2-dependent cytokine response. The attenuated MHV3 variants, 51.6-MHV3 and YAC-MHV3, are characterized by a weak tropism for LSECs and induce moderated and subclinical hepatitis respectively. Given the importance of LSECs in hepatic tolerance and the elimination of circulating pathogens, it has been postulated that the severity of hepatitis and inflammatory response induced by MHVs correlates with infection and alterations in vascular and tolerogenic properties of LSECs. Hepatic inflammatory disorders may result from differential activation of TLR2, rather than other TLRs and helicases, according to serotypes. Moreover, given the role of BMECs in preventing CNS infections, it has been postulated that secondary cerebral invasion by coronaviruses is related to infection of BMECs and subsequent breakdown of the blood-brain barrier (BBB). Through in vitro and in vivo infections of isolated BMECs, LSECs or mice with the different MHVs, we demonstrated, first, that in vitro productive infection of LSECs by the highly virulent MHV3 serotype, in contrast to 51.6- et YAC-MHV3 variants, altered their production of vasoactive factors and overthrew their intrinsic tolerogenic properties by promoting inflammatory cytokines and chemokines production. These disturbances were reflected in vivo by an uncontrolled inflammatory response and a deregulation of intrahepatic leukocyte recruitment, favoring viral replication and liver damages. We demonstrated, using TLR2 KO mice and LSECs treated with siRNA for TLR2 that the abnormal inflammatory response induced by MHV3 depended in part on preferential induction and activation of TLR2 by the virus on the surface of hepatic cells. Moreover, the severity of the primary viral replication in the liver and disorders in intrahepatic leucocyte recruitment induced by MHV3, but not by MHV-A59 and 51.6-MHV3, correlated with a subsequent brain invasion at the BBB level. Such invasion was related to productive infection of BMECs and subsequent IFN--dependent disruption of tight junction proteins occludin, VE-cadherin and ZO-1, resulting in an increase of BBB permeability and further viral entry into the CNS. Overall, the results of this study highlight the importance of structural and functional integrity of LSECs and BMECs during acute viral infections by MHVs to limit liver damages associated with viral-induced exacerbation of inflammatory response and prevent brain invasion by MHVs following viral spread through the bloodstream. They also reveal a new worsening role for TLR2 in the evolution of acute viral hepatitis paving the way for new therapies targeting TLR2-induced inflammatory activity.

Reverse genetics is an innovative molecular biology tool that enables the manipulation of viral genomes at the cDNA level in order to generate particular mutants or artificial viruses. The reverse genetics system for the influenza virus is arguably one of the best illustrations of the potential power of this technology. This reverse genetics system is the basis for the ability to regularly adapt influenza vaccines strains. Today, reverse genetic systems have been developed for many animal RNA viruses. Selection-free reverse genetics systems have been developed for the members of the Reoviridae family including, African horsesickness virus, bluetongue virus and orthoreovirus. This ground-breaking technology has led to the generation of valuable evidence regarding the replication and pathogenesis of these viruses. Unfortunately, extrapolating either the plasmid-based or transcript-based reverse genetics systems to rotavirus has not yet been successful. The development of a selection-free rotavirus reverse genetics system will enable the systematic investigation of poorly understood aspects of the rotavirus replication cycle and aid the development of more effective vaccines, amongst other research avenues. This study investigated the importance of co-expressed rotavirus proteins in the development of a selection-free rotavirus reverse genetics system. The consensus sequences of the rotavirus strains Wa (RVA/Human-tc/USA/WaCS/1974/G1P[8]) and SA11 (RVA/Simian-tc/ZAF/SA11/1958/G3P[2]) where used to design rotavirus expression plasmids. The consensus nucleotide sequence of a human rotavirus Wa strain was determined by sequence-independent cDNA synthesis and amplification combined with next-generation 454® pyrosequencing. A total of 4 novel nucleotide changes, which also resulted in amino acid changes, were detected in genome segment 7 (NSP3), genome segment 9 (VP7) and genome segment 10 (NSP4). In silico analysis indicated that none of the detected nucleotide changes, and consequent amino acid variations, had any significant effect on viral structure. Evolutionary analysis indicated that the sequenced rotavirus WaCS was closely related to the ParWa and VirWa variants, which were derived from the original 1974 Wa isolate. Despite serial passaging in animals, as well as cell cultures, the Wa genome seems to be stable. Considering that the current reference sequence for the Wa strain is a composite sequence of various Wa variants, the rotavirus WaCS may be a more appropriate reference sequence. The rotavirus Wa and SA11 strains were selected for plasmid-based expression of rotavirus proteins, under control of a T7 promoter sequence, due to the fact that they propagate well in MA104 cells and the availability of their consensus sequences. The T7 RNA polymerase was provided by a recombinant fowlpox virus. After extensive transfection optimisation on a variety of mammalian cell lines, MA104 cells proved to be the best suited for the expression rotavirus proteins from plasmids. The expression of rotavirus Wa and SA11 VP1, VP6, NSP2 and NSP5 could be confirmed with immunostaining in MA104 and HEK 293H cells. Another approach involved the codon-optimised expression of the rotavirus replication complex scaffold in MA104 cells under the control of a CMV promoter sequence. This system was independent from the recombinant fowlpox virus. All three plasmid expression sets were designed to be used in combination with the transcript-based reverse genetics system in order to improve the odds of developing a successful rotavirus reverse genetics system. Rotavirus transcripts were generated using transcriptively active rotavirus SA11 double layered particles (DLPs). MA104 and HEK293H cells proved to be the best suited for the expression of rotavirus transcripts although expression of rotavirus VP6 could be demonstrated in all cell cultures examined (MA104, HEK 293H, BSR and COS-7) using immunostaining. In addition, the expression of transcript derived rotavirus VP1, NSP2 and NSP5 could be confirmed with immunofluorescence in MA104 and HEK 293H cells. This is the first report of rotavirus transcripts being translated in cultured cells. A peculiar cell death pattern was observed within 24 hours in response to transfection of rotavirus transcripts. This observed cell death, however does not seem to be related to normal viral cytopathic effect as no viable rotavirus could be recovered. In an effort to combine the transcript- and plasmid systems, a dual transfection strategy was followed where plasmids encoding rotavirus proteins were transfected first followed, 12 hours later, by the transfection of rotavirus SA11 transcripts. The codon- optimised plasmid system was designed as it was postulated that expression of the DLP-complex (VP1, VP2, VP3 and VP6), the rotavirus replication complex would form and assist with replication and/or packaging. Transfecting codon- optimized plasmids first noticeably delayed the mass cell death observed when transfecting rotavirus transcripts on their own. None of the examined coexpression systems were able to produce a viable rotavirus. Finally, the innate immune responses elicited by rotavirus transcripts and plasmid-derived rotavirus Wa and SA11 proteins were investigated. Quantitative RT-PCR (qRT-PCR) experiments indicated that rotavirus transcripts induced high levels of the expression of the cytokines IFN- α1, IFN-1β, IFN-λ1 and CXCL10. The expression of certain viral proteins from plasmids (VP3, VP7 and NSP5/6) was more likely to stimulate specific interferon responses, while other viral proteins (VP1, VP2, VP4 and NSP1) seem to be able to actively suppress the expression of certain cytokines. In the light of these suppression results, specific rotavirus proteins were expressed from transfected plasmids to investigate their potential in supressing the interferon responses provoked by rotavirus transcripts. qRT-PCR results indicated that cells transfected with the plasmids encoding NSP1, NSP2 or a combination of NSP2 and NSP5 significantly reduced the expression of specific cytokines induced by rotavirus transcripts. These findings point to other possible viral innate suppression mechanisms in addition to the degradation of interferon regulatory factors by NSP1. The suppression of the strong innate immune response elicited by rotavirus transcripts might well prove to be vital in the quest to better understand the replication cycle of this virus and eventually lead to the development of a selection-free reverse genetics system for rotavirus. / PhD (Biochemistry), North-West University, Potchefstroom Campus, 2014

Reverse genetics is an innovative molecular biology tool that enables the manipulation of viral genomes at the cDNA level in order to generate particular mutants or artificial viruses. The reverse genetics system for the influenza virus is arguably one of the best illustrations of the potential power of this technology. This reverse genetics system is the basis for the ability to regularly adapt influenza vaccines strains. Today, reverse genetic systems have been developed for many animal RNA viruses. Selection-free reverse genetics systems have been developed for the members of the Reoviridae family including, African horsesickness virus, bluetongue virus and orthoreovirus. This ground-breaking technology has led to the generation of valuable evidence regarding the replication and pathogenesis of these viruses. Unfortunately, extrapolating either the plasmid-based or transcript-based reverse genetics systems to rotavirus has not yet been successful. The development of a selection-free rotavirus reverse genetics system will enable the systematic investigation of poorly understood aspects of the rotavirus replication cycle and aid the development of more effective vaccines, amongst other research avenues. This study investigated the importance of co-expressed rotavirus proteins in the development of a selection-free rotavirus reverse genetics system. The consensus sequences of the rotavirus strains Wa (RVA/Human-tc/USA/WaCS/1974/G1P[8]) and SA11 (RVA/Simian-tc/ZAF/SA11/1958/G3P[2]) where used to design rotavirus expression plasmids. The consensus nucleotide sequence of a human rotavirus Wa strain was determined by sequence-independent cDNA synthesis and amplification combined with next-generation 454® pyrosequencing. A total of 4 novel nucleotide changes, which also resulted in amino acid changes, were detected in genome segment 7 (NSP3), genome segment 9 (VP7) and genome segment 10 (NSP4). In silico analysis indicated that none of the detected nucleotide changes, and consequent amino acid variations, had any significant effect on viral structure. Evolutionary analysis indicated that the sequenced rotavirus WaCS was closely related to the ParWa and VirWa variants, which were derived from the original 1974 Wa isolate. Despite serial passaging in animals, as well as cell cultures, the Wa genome seems to be stable. Considering that the current reference sequence for the Wa strain is a composite sequence of various Wa variants, the rotavirus WaCS may be a more appropriate reference sequence. The rotavirus Wa and SA11 strains were selected for plasmid-based expression of rotavirus proteins, under control of a T7 promoter sequence, due to the fact that they propagate well in MA104 cells and the availability of their consensus sequences. The T7 RNA polymerase was provided by a recombinant fowlpox virus. After extensive transfection optimisation on a variety of mammalian cell lines, MA104 cells proved to be the best suited for the expression rotavirus proteins from plasmids. The expression of rotavirus Wa and SA11 VP1, VP6, NSP2 and NSP5 could be confirmed with immunostaining in MA104 and HEK 293H cells. Another approach involved the codon-optimised expression of the rotavirus replication complex scaffold in MA104 cells under the control of a CMV promoter sequence. This system was independent from the recombinant fowlpox virus. All three plasmid expression sets were designed to be used in combination with the transcript-based reverse genetics system in order to improve the odds of developing a successful rotavirus reverse genetics system. Rotavirus transcripts were generated using transcriptively active rotavirus SA11 double layered particles (DLPs). MA104 and HEK293H cells proved to be the best suited for the expression of rotavirus transcripts although expression of rotavirus VP6 could be demonstrated in all cell cultures examined (MA104, HEK 293H, BSR and COS-7) using immunostaining. In addition, the expression of transcript derived rotavirus VP1, NSP2 and NSP5 could be confirmed with immunofluorescence in MA104 and HEK 293H cells. This is the first report of rotavirus transcripts being translated in cultured cells. A peculiar cell death pattern was observed within 24 hours in response to transfection of rotavirus transcripts. This observed cell death, however does not seem to be related to normal viral cytopathic effect as no viable rotavirus could be recovered. In an effort to combine the transcript- and plasmid systems, a dual transfection strategy was followed where plasmids encoding rotavirus proteins were transfected first followed, 12 hours later, by the transfection of rotavirus SA11 transcripts. The codon- optimised plasmid system was designed as it was postulated that expression of the DLP-complex (VP1, VP2, VP3 and VP6), the rotavirus replication complex would form and assist with replication and/or packaging. Transfecting codon- optimized plasmids first noticeably delayed the mass cell death observed when transfecting rotavirus transcripts on their own. None of the examined coexpression systems were able to produce a viable rotavirus. Finally, the innate immune responses elicited by rotavirus transcripts and plasmid-derived rotavirus Wa and SA11 proteins were investigated. Quantitative RT-PCR (qRT-PCR) experiments indicated that rotavirus transcripts induced high levels of the expression of the cytokines IFN- α1, IFN-1β, IFN-λ1 and CXCL10. The expression of certain viral proteins from plasmids (VP3, VP7 and NSP5/6) was more likely to stimulate specific interferon responses, while other viral proteins (VP1, VP2, VP4 and NSP1) seem to be able to actively suppress the expression of certain cytokines. In the light of these suppression results, specific rotavirus proteins were expressed from transfected plasmids to investigate their potential in supressing the interferon responses provoked by rotavirus transcripts. qRT-PCR results indicated that cells transfected with the plasmids encoding NSP1, NSP2 or a combination of NSP2 and NSP5 significantly reduced the expression of specific cytokines induced by rotavirus transcripts. These findings point to other possible viral innate suppression mechanisms in addition to the degradation of interferon regulatory factors by NSP1. The suppression of the strong innate immune response elicited by rotavirus transcripts might well prove to be vital in the quest to better understand the replication cycle of this virus and eventually lead to the development of a selection-free reverse genetics system for rotavirus. / PhD (Biochemistry), North-West University, Potchefstroom Campus, 2014